ReviewFrontiers in immunology2026
The role of lipid metabolism and creeping fat in disease assessment and prediction for Crohn's disease.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Crohn's Disease (CD) is a chronic disease that often leads to disability. Effective monitoring of the disease is essential for delaying progression and improving outcomes. Traditional assessment methods have some limitations, such as invasiveness, delayed response, or inability to evaluate transmural lesions. This review focuses on lipid metabolism and creeping fat (CF) and explores their roles in disease prediction and assessment of CD. Through literature review, this study summarized the currently commonly used methods for assessing the condition, and also summarized the relationships among blood lipids, inflammation, and adipose tissue, as well as their effects during the disease activity period of CD. The methods for CD to assess the condition include endoscopy, radiological examination and endoscopic ultrasound and so on. During active phase, patients often show characteristic dyslipidemia. These lipid changes are closely related to systemic inflammation severity. As a unique feature in CD, CF consists of mesenteric fat expansion and bowel wrapping, contributing to intestinal inflammation, fibrosis, and stricture formation. Immune responses, microbial factors, and molecular pathways are involved in this process. Current imaging techniques enable the assessment of CF for predicting surgical risks and postoperative recurrence. Considering the close correlation between lipid levels and CF and the inflammation during the active phase of CD, there is potential for disease assessment. In the future, we should focus on the application of lipid levels and CF in assessing and predicting the activity of CD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.